Millennium Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,527,375
Closed -$15.3M 7054
2022
Q4
$15.3M Sell
1,527,375
-2
-0% -$20 0.01% 1682
2022
Q3
$15M Sell
1,527,377
-3,024
-0.2% -$29.7K 0.01% 1651
2022
Q2
$15M Buy
1,530,401
+59,908
+4% +$586K 0.01% 1589
2022
Q1
$14.4M Buy
1,470,493
+117,708
+9% +$1.14M 0.01% 1737
2021
Q4
$13.2M Sell
1,352,785
-10,937
-0.8% -$106K 0.01% 1849
2021
Q3
$13.2M Buy
1,363,722
+1,006,994
+282% +$9.76M 0.01% 1727
2021
Q2
$3.48M Buy
+356,728
New +$3.49M ﹤0.01% 3252

Other funds holding AONC

Millennium Management's AONC Position: Q1 2023 in Review

Millennium Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 1,527,375 shares — an estimated $15.3M sold.

Millennium Management first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $15.3M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Millennium Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Millennium Management sold 1,527,375 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $15.3M.
  • Millennium Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
  • Millennium Management's American Oncology Network, Inc. Class A Common Stock position peaked at $15.3M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.